Medtronic has canceled a $738 million deal to acquire the wearable insulin pump maker EOFlow Co., according to a Dec. 6 Securities and Exchange Commission filing.
Read the full post on Becker's Hospital Review - Healthcare News
Medtronic scraps $738M deal for insulin pump maker
